The coronavirus pandemic has triggered a massive, worldwide effort to develop effective vaccines and treatments. With a previous focus on cancer, Pascal’s scientists directed their efforts to discovering a cannabinoid-based treatment for COVID-19. Pascal made the decision to test cannabinoids…
Read MoreB cell precursor acute lymphoblastic leukemia (BCP-ALL or ALL) is a challenging hematologic malignancy with significant unmet medical need. More than 6000 patients are diagnosed with ALL each year in the US and Canada. About half of ALL patients are…
Read MoreCannabinoid-based therapeutic for glioblastoma PAS-403 (previously known as ST-403) is a mitosis inhibitor that blocks cell division. The cannabinoid-based product is undergoing development for the treatment of glioblastoma and brain metastases originating from other cancers. Several mitotic inhibitors approved for…
Read MoreCannabinoid-based therapeutic for restoring immune recognition Advanced cancers typically become invisible to the immune system, thus allowing them to evade elimination. PAS-393 is a cannabinoid designed to restore the immunogenicity of tumor cells, thus rendering these cells once again susceptible…
Read More